Public Health Agency of Canada

23 datasets found
  • Open Information

    Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 y...

    The Pfizer-BioNTech and Moderna COVID-19 vaccines are mRNA vaccines that were initially authorized by Health Canada for use in individuals 16 and 18 years of age and older, respectively, in December 2020. On May 5, 2021, Health Canada expanded the Interim Order authorization for the...
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
  • Open Information

    Vaccination and pregnancy: After pregnancy

    If you missed certain vaccines before or during pregnancy, you should get them after your baby is born. This will lower the chance that you'll get a vaccine-preventable disease and spread it to your baby. This is especially important while your baby is too young to receive certain vaccines.
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
  • Open Information

    COVID-19: Effectiveness and benefits of vaccination

    Vaccination is one of the most effective ways to protect our families, communities and ourselves against COVID-19. Evidence indicates that vaccines are very effective at preventing severe illness, hospitalization and death from COVID-19, including against Alpha and Delta variants of concern....
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
  • Open Information

    Adjusting public health measures in the context of COVID-19 vaccination

    As COVID-19 continues to circulate in Canada and more people are getting vaccinated, different public health measures (PHMs) may be required, based on the level of transmission and other key indicators outlined below. This interim guidance provides considerations for adjusting PHMs in the context...
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
  • Open Information

    COVID-19 for heath professionals: Post COVID-19 condition

    The World Health Organization (WHO) refers to symptoms lasting for weeks or months after a COVID-19 infection as post COVID-19 condition. Some studies have reported later symptoms in patients with a severe COVID-19 infection. For example, those who were hospitalized or needed intensive care...
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
  • Open Information

    How to quarantine (self-isolate) at home when you may have been exposed to CO...

    People with COVID-19 do not always recognize their early symptoms. Even if you do not have symptoms now, it is possible to transmit COVID-19 before you start showing symptoms or without ever developing symptoms. You need to quarantine (self-isolate) for 14 days at home when you may have been...
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
  • Open Information

    SARS-CoV-2 variants: National definitions, classifications and public health ...

    The Public Health Agency of Canada, in collaboration with provincial and territorial public health authorities, established the Canadian SARS-CoV-2 Variant Surveillance Group (CSVSG) to monitor and assess the impact of variants of SARS-CoV-2 on viral transmissibility, disease severity, and...
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
  • Open Information

    Health Promotion and Chronic Disease Prevention in Canada, Vol 41, No 5, May ...

    Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice (the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada. The journal publishes articles on disease...
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
  • Open Information

    CCDR: Volume 47-4, April 2021: COVID-19: A Year Later

    The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
  • Open Information

    CCDR: Volume 46-11/12- November 2020: Oral Health in Canada

    The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
    • PDF
  • Open Information

    CCDR: Volume 46-10-October 2020: Laboratory Biosafety

    The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
    • PDF
  • Open Information

    CCDR: Volume 46-9-September 2020: Force Health Protection

    The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML
    • PDF
  • Open Information

    COVID-19 in Canada: Modelling update

    Data to keep Canadians up to date on where we are and models to understand where we might be heading in the COVID-19 epidemic.
    Organization:
    Public Health Agency of Canada
    Resource Formats:
    • HTML